Altered threonine tyrosine kinase (TTK) expression is associated with adverse clinical outcomes in breast tumors: An in silico approach. RSD [Internet]. 2023 Nov. 27 [cited 2025 Jun. 28];12(13):e40121344285. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/44285